News & Updates

Show Multimedia Only
Dolutegravir: A better choice for HIV viral suppression in pregnancy?

Dolutegravir: A better choice for HIV viral suppression in pregnancy?

13 Nov 2022 byRoshini Claire Anthony

Among pregnant individuals on antiretroviral therapy (ART) for HIV-1 infection, those on dolutegravir had the greatest viral suppression rates at delivery, a recent US-based observational study showed. However, birth outcomes generally did not differ between dolutegravir recipients and those on various other ART regimens.

13 Nov 2022
Polygenic risk scores predict response to ECT for major depressive disorder

Polygenic risk scores predict response to ECT for major depressive disorder

13 Nov 2022

A polygenic liability for major depressive disorder and bipolar disorder contributes to improvements following electroconvulsive therapy (ECT), reports a study. This provides evidence of a genetic factor for clinical response to ECT.

13 Nov 2022